Methodology Concerns Regarding Claims Data Studies in Transgender Health
To the Editor The recent study by Manfredi et al1 found a lower prevalence of prostate cancer (PC) in transgender women undergoing gender-affirming hormone therapy (GAHT), but a correlation between GAHT and more aggressive PC. We have concerns regarding the analyses and conclusions.
Authors
- Alberto Giovanni Leone (ORCID: https://orcid.org/0000-0001-9365-2160)
- Don S. Dizon (ORCID: https://orcid.org/0000-0001-6541-9580)
- Ole‐Petter R. Hamnvik (ORCID: https://orcid.org/0000-0002-3600-2628)
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Providence College (US)
- Brown University (US)
- Chelsea and Westminster Hospital (GB)
- Lifespan (US)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
Publication Details
- Journal
- JAMA Oncology
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1001/jamaoncol.2025.0020
- Citations
- 2
- Primary Topic
- LGBTQ Health, Identity, and Policy
- Type
- article
- Field-Weighted Citation Impact
- 4.88